QT Imaging Holdings Announces $500,000 Insiders PIPE Investment
QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. The investment comes from Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu, who agreed to purchase 784,929 unregistered common stock shares at $0.637 per share on April 9, 2025.
The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The share price represents a 10% premium to the company's volume weighted average trading price. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.
QT Imaging Holdings (OTCQB:QTIH) ha ottenuto un investimento PIPE di 500.000 dollari da parte di membri interni dell'azienda. L'investimento proviene dal Presidente del Consiglio Dr. Avi Katz e dall'Amministratore Delegato Dr. Raluca Dinu, che hanno concordato di acquistare 784.929 azioni ordinarie non registrate a 0,637 dollari per azione il 9 aprile 2025.
L'accordo include 1.569.858 warrant con un prezzo di esercizio di 0,72 dollari per azione. Il prezzo delle azioni rappresenta un premio del 10% rispetto al prezzo medio ponderato per volume dell'azienda. Il finanziamento, previsto per chiudere entro il 24 aprile 2025, è stato effettuato direttamente da QTI senza spese bancarie. I proventi saranno utilizzati come capitale circolante per supportare la crescita dell'azienda.
QT Imaging Holdings (OTCQB:QTIH) ha conseguido una inversión PIPE de 500,000 dólares de parte de miembros internos de la empresa. La inversión proviene del Presidente de la Junta Dr. Avi Katz y de la CEO Dr. Raluca Dinu, quienes acordaron comprar 784,929 acciones ordinarias no registradas a 0.637 dólares por acción el 9 de abril de 2025.
El acuerdo incluye 1,569,858 warrants con un precio de ejercicio de 0.72 dólares por acción. El precio de las acciones representa una prima del 10% sobre el precio promedio ponderado por volumen de la empresa. El financiamiento, que se espera cierre para el 24 de abril de 2025, fue realizado directamente por QTI sin comisiones bancarias. Los ingresos se utilizarán como capital de trabajo para apoyar el crecimiento del negocio de la empresa.
QT Imaging Holdings (OTCQB:QTIH)는 회사 내부자들로부터 50만 달러의 PIPE 투자를 확보했습니다. 이 투자는 이사회 의장인 Dr. Avi Katz와 CEO인 Dr. Raluca Dinu가 2025년 4월 9일 주당 0.637달러에 등록되지 않은 일반 주식 784,929주를 구매하기로 합의하면서 이루어졌습니다.
이번 거래에는 주당 0.72달러의 행사 가격을 가진 1,569,858개의 워런트가 포함되어 있습니다. 주가 는 회사의 거래량 가중 평균 가격보다 10% 프리미엄을 나타냅니다. 2025년 4월 24일까지 마감될 것으로 예상되는 이 자금 조달은 QTI가 직접 진행하며 은행 수수료는 없습니다. 수익금은 회사의 사업 성장을 지원하기 위한 운영 자본으로 사용될 것입니다.
QT Imaging Holdings (OTCQB:QTIH) a sécurisé un investissement PIPE de 500 000 dollars de la part d'insiders de l'entreprise. L'investissement provient du Président du Conseil Dr. Avi Katz et de la CEO Dr. Raluca Dinu, qui ont accepté d'acheter 784 929 actions ordinaires non enregistrées au prix de 0,637 dollars par action le 9 avril 2025.
L'accord comprend 1 569 858 bons de souscription avec un prix d'exercice de 0,72 dollars par action. Le prix des actions représente une prime de 10 % par rapport au prix moyen pondéré par le volume de l'entreprise. Le financement, qui devrait être finalisé d'ici le 24 avril 2025, a été réalisé directement par QTI sans frais bancaires. Les recettes seront utilisées comme fonds de roulement pour soutenir la croissance de l'entreprise.
QT Imaging Holdings (OTCQB:QTIH) hat eine PIPE-Investition in Höhe von 500.000 Dollar von Unternehmensinsidern gesichert. Die Investition stammt von dem Vorstandsvorsitzenden Dr. Avi Katz und der CEO Dr. Raluca Dinu, die am 9. April 2025 vereinbart haben, 784.929 nicht registrierte Stammaktien zu einem Preis von 0,637 Dollar pro Aktie zu erwerben.
Das Geschäft umfasst 1.569.858 Warrants mit einem Ausübungspreis von 0,72 Dollar pro Aktie. Der Aktienpreis stellt eine Prämie von 10 % gegenüber dem volumen-gewichteten Durchschnittspreis des Unternehmens dar. Die Finanzierung, die voraussichtlich bis zum 24. April 2025 abgeschlossen sein wird, wurde direkt von QTI ohne Bankgebühren platziert. Die Erlöse werden als Betriebskapital verwendet, um das Unternehmenswachstum zu unterstützen.
- Insider investment demonstrates management confidence
- 10% share price premium to market value
- No banking fees, maximizing capital efficiency
- Additional working capital secured for growth
- Small investment amount of only $500,000
- Potential dilution from warrant exercise
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the closing of the PIPE, the intended use of proceeds from the PIPE, the filing of a registration statement covering the resale of the securities being sold, and the Company’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding its future business plans. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250410121647/en/
For media inquiries, please contact:
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com
Source: QT Imaging Holdings, Inc.
FAQ
What is the size and purpose of QTIH's recent PIPE investment?
What is the share price and premium in QTIH's April 2025 PIPE deal?
How many shares and warrants are included in QTIH's insider investment?
When is QTIH's PIPE investment expected to close?
